<DOC>
	<DOC>NCT00287417</DOC>
	<brief_summary>The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.</brief_summary>
	<brief_title>Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<criteria>Female &gt; 18 years old Pregnant Maternal age &lt; 18 years old, twin pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Nucal translucency</keyword>
	<keyword>Down syndrome</keyword>
	<keyword>MSS</keyword>
	<keyword>Risk assessment</keyword>
</DOC>